Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in…

Overview of attention for article published in Neuropsychiatric Disease and Treatment, June 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

patent: 5 patents

peer_reviews: 1 peer review site

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 67 Mendeley

Summary Patents Peer reviews Dimensions citations

So far, Altmetric has seen 5 patents that reference this research output.

Transdermal therapeutic system containing asenapine

Grant US-11648213-B2

United States of America

Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene

Grant US-11337932-B2

United States of America

Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer

Grant US-11033512-B2

United States of America

Transdermal therapeutic system containing asenapine

Grant US-10980753-B2

United States of America

Transdermal therapeutic system containing asenapine

Grant US-10898449-B2

United States of America